SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Biotechnology Cancer Cures
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Oravetz who wrote (212)1/16/2001 2:40:15 PM
From: Jibacoa   of 226
 
It is good to have more options to treat those patients.

Of course the FDA approval of Femara will not have the impact on Novartis that an FDA approval of Theratope would have for Biomira.

As stated on your note:
"More than 120,000 women in the United States have advanced breast cancer, the second leading cause of cancer death among American women.
Approximately half of the 182,000 newly diagnosed cases of breast cancer each year are already in an advanced stage when they are detected."

There is no question that we still need some new and better ways of dealing with this problem.

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News